PHI with Cerebral Deep Brain Stimulation
How does this condition affect your private health insurance?
Deep Brain Stimulation (DBS) is a neurosurgical procedure involving the implantation of electrodes within certain brain areas, connected to a neurostimulator (a device similar to a pacemaker) placed under the skin in the chest. It delivers electrical impulses to specific brain targets, modulating abnormal brain activity. DBS is primarily used to treat symptoms of chronic neurological conditions like Parkinson's disease, essential tremor, and dystonia, when medications are no longer adequately effective or cause intolerable side effects. It aims to improve motor symptoms such as tremor, rigidity, and bradykinesia, significantly enhancing quality of life for many patients.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
The underlying neurological condition (e.g., Parkinson's) typically exists for several years (5-10+ years) before DBS is considered.
Duration of Illness (Lifetime)
The underlying neurological conditions treated by DBS (e.g., Parkinson's, essential tremor) are chronic and progressive, lasting a lifetime. DBS offers symptomatic relief but is not a cure.
Cost of Treatment (Initial)
The initial cost for DBS surgery, including device implantation and initial programming, is substantial, often ranging from $35,000 to over $100,000 USD.
Cost of Treatment (Lifetime)
Lifetime costs include follow-up programming, neurologist visits, potential battery replacements (every 3-5 years for non-rechargeable systems), and ongoing medication, potentially adding tens of thousands of dollars over decades.
Mortality Rate
The probability of death directly related to DBS surgery is very low, estimated at less than 0.5-1%, primarily due to risks like intracranial hemorrhage or infection.
Risk of Secondary Damages
Moderate. Surgical risks include intracranial hemorrhage (1-5%), infection (2-10%), stroke, or seizures. Post-surgical risks involve hardware malfunction or stimulation-related side effects such as speech problems, balance issues, or mood changes, requiring programming adjustments.
Probability of Full Recovery
Very low. DBS is a symptomatic treatment and does not cure the underlying progressive neurological disease. It significantly improves symptoms but does not prevent disease progression, so a complete recovery without consequences is not typically achievable for the primary condition.
Underlying Disease Risk
DBS is performed for existing neurological diseases (e.g., Parkinson's, essential tremor). Patients with these conditions often have comorbidities like depression, anxiety, or cognitive impairment. The probability of such other underlying diseases varies based on the primary condition.